BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2

BTSG, OPHC, HRTG, UMC and MTG have been added to the Zacks Rank #1 (Strong Buy) List on August 26th,

CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.

Sandisk, Celestica and BrightSpring rank among profitable stocks, with strong net income ratios and

CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforc

IBKR, ROKU and BTSG are thriving on Nasdaq, backed by product expansion, streaming growth and care m

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recogni

The Benzinga Stock Whisper Index highlights five unique stocks each week that attract high reader an

BTSG's nearly 59% YTD surge is backed by 23% revenue growth, rising margins and expansion in special

Bellars Harris Wealth Management LLC purchased a new stake in BrightSpring Health Services, Inc. (NA

Small-cap stocks are surging, but how you own them matters more than most investors realize.

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $

BTSG's specialty, infusion and home health momentum support growth, while IRA pressure and customer

Bloom Energy's stock performed well as market adoption for its fuel cell offering continued to gain

Bank of America Corp DE boosted its position in BrightSpring Health Services, Inc. (NASDAQ: BTSG) by

BrightSpring Health Services (BTSG) has delivered 22% revenue CAGR over five years, with strong segm

BTSG Health Services raises its 2026 outlook as Pharmacy and Provider growth, margin gains and lower

Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improv

Micron, BrightSpring Health and Custom Truck One Source combine strong profitability with earnings g

BrightSpring Health is converting its large pharmacy revenue base into faster gross profit and EBITD

BJ's Restaurants, Patterson-UTI Energy and BrightSpring Health Services stand out after recent broke

Investors need to pay close attention to BTSG stock based on the movements in the options market lat

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $

BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the anal

BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion t

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260714-1484349/1484349_gtls46.

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Keybanc analyst Matthew Gillmor maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Guggenheim analyst Jason Cassorla initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Consider

Raymond James analyst Parker Snure initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price

B of A Securities analyst Kevin Fischbeck maintains BrightSpring Health (NASDAQ:BTSG) with a Buy

Top Wall Street analysts changed outlook on top names. See all changes, including upgrades/downgrade

BTIG analyst David Larsen maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the p

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises

Goldman Sachs analyst Scott Fidel initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a

BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"),

BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"),

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-

Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises

BrightSpring Health Services (BTSG) reported strong Q1 results with increased full-year guidance. An

Keybanc analyst Matthew Gillmor maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and

Stephens & Co. analyst Raj Kumar maintains BrightSpring Health (NASDAQ:BTSG) with a Overweig

BMO Capital analyst Sean Dodge maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and

Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday.